DK412284D0 - Vacciner baseret paa membran-bundne proteiner og fremgangsmaade til fremstilling deraf - Google Patents

Vacciner baseret paa membran-bundne proteiner og fremgangsmaade til fremstilling deraf

Info

Publication number
DK412284D0
DK412284D0 DK412284A DK412284A DK412284D0 DK 412284 D0 DK412284 D0 DK 412284D0 DK 412284 A DK412284 A DK 412284A DK 412284 A DK412284 A DK 412284A DK 412284 D0 DK412284 D0 DK 412284D0
Authority
DK
Denmark
Prior art keywords
membrane
procedure
producing
vaccines based
bonded proteins
Prior art date
Application number
DK412284A
Other languages
English (en)
Other versions
DK412284A (da
DK172694B1 (da
Inventor
Phillip Wayne Berman
Laurence Allan Lasky
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27414978&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK412284(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK412284D0 publication Critical patent/DK412284D0/da
Publication of DK412284A publication Critical patent/DK412284A/da
Priority to DK199701244A priority Critical patent/DK173597B1/da
Application granted granted Critical
Publication of DK172694B1 publication Critical patent/DK172694B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK198404122A 1983-08-30 1984-08-29 Vacciner indeholdende glycoprotein C eller D fra herpes simplex virus DK172694B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK199701244A DK173597B1 (da) 1983-08-30 1997-10-31 Fremgangsmåde til fremstilling af et membranfrit trunkat af et membranbundet polypeptid

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US52791783A 1983-08-30 1983-08-30
US52791783 1983-08-30
US54755183A 1983-10-31 1983-10-31
US54755183 1983-10-31
US58817084A 1984-03-09 1984-03-09
US58817084 1984-03-09

Publications (3)

Publication Number Publication Date
DK412284D0 true DK412284D0 (da) 1984-08-29
DK412284A DK412284A (da) 1985-04-11
DK172694B1 DK172694B1 (da) 1999-05-31

Family

ID=27414978

Family Applications (2)

Application Number Title Priority Date Filing Date
DK198404122A DK172694B1 (da) 1983-08-30 1984-08-29 Vacciner indeholdende glycoprotein C eller D fra herpes simplex virus
DK009197A DK9197A (da) 1983-08-30 1997-01-24 Vaccine baseret på membranbundne proteiner og fremgangsmåde til fremstilling deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK009197A DK9197A (da) 1983-08-30 1997-01-24 Vaccine baseret på membranbundne proteiner og fremgangsmåde til fremstilling deraf

Country Status (13)

Country Link
US (1) US5851533A (da)
EP (1) EP0139417B2 (da)
JP (2) JP2599350B2 (da)
AU (1) AU579323B2 (da)
CA (1) CA1341181C (da)
DE (1) DE3479085D1 (da)
DK (2) DK172694B1 (da)
ES (2) ES8605039A1 (da)
GR (1) GR80220B (da)
HK (1) HK98792A (da)
IE (1) IE58030B1 (da)
IL (1) IL72785A (da)
NZ (1) NZ209308A (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
US6534285B1 (en) 1984-12-24 2003-03-18 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
US5853978A (en) * 1985-12-04 1998-12-29 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation
GR862472B (en) * 1986-09-30 1986-10-09 Elliniko Institouto Paster Determination of antibodies specific of hsv-1 herpes or hsv-2 in human serum with the elisa technic using the specific antigen of hsv-1 or hsv-2 type in semi - clean form
IE81149B1 (en) 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
US5976839A (en) * 1987-03-13 1999-11-02 Bioenterprises Pty Limited Immunopotentiation through covalent linkage between immunogen and immunopotentiating molecules
WO1990013652A1 (en) * 1989-05-12 1990-11-15 Triton Diagnostics, Inc. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
JPH05501951A (ja) * 1989-07-31 1993-04-15 ニコルズ　インスティテュート　ダイアグノスティクス 組換えヒト甲状腺ペルオキシダーゼ
EP0541692B1 (en) * 1990-08-02 1999-05-06 Chiron Corporation Herpes simplex virus vp16 vaccines
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
AU2555792A (en) * 1991-08-28 1993-04-05 Nichols Institute Diagnostics Disease associated human autoantibodies specific for human thyroid peroxidase
PT761231E (pt) 1992-06-25 2000-06-30 Smithkline Beecham Biolog Composicao de vacina contendo adjuvantes
WO1999005161A1 (en) 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR
US6692752B1 (en) 1999-09-08 2004-02-17 Smithkline Beecham Biologicals S.A. Methods of treating human females susceptible to HSV infection
US20020090382A1 (en) * 2000-08-01 2002-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Antiviral compounds and methods
MXPA04000653A (es) 2001-07-27 2004-11-22 Chiron Srl Adhesinas de meningococcus nada, app y orf 40.
JP2004099584A (ja) * 2002-05-02 2004-04-02 Keio Gijuku Ｈｓｖを用いた抗腫瘍剤
EP1670507A4 (en) 2003-09-12 2007-10-17 Antigenics Inc VACCINE FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY HERPES SIMPLEX VIRUS
BRPI0518284A2 (pt) 2004-11-24 2008-11-11 Shell Int Research aparelhos para separar substancialmente um fluxo em duas fases em um componente gasoso e um componente lÍquido, para separar substancialmente um fluxo de mistura em um componente lÍquido e pelo menos outro componente lÍquido e um componente gasoso e para separar substancialmente um fluxo de mistura em partes componentes com base nas densidades das partes componentes, sistema para separar substancialmente um fluxo de mistura em partes componentes, e, mÉtodos para separar substancialmente um fluxo tampço e para projetar um separador para separar substancialmente um fluxo tampço
AU2007292905B2 (en) 2006-09-08 2013-05-23 The Trustees Of The University Of Pennsyvania HSV-1 and HSV-2 vaccines and methods of use thereof
US8865185B2 (en) 2006-09-08 2014-10-21 The Trustees Of The University Of Pennsylvania Methods of use for HSV-1 and HSV-2 vaccines
WO2008085486A1 (en) * 2006-12-28 2008-07-17 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US10478490B2 (en) 2006-12-28 2019-11-19 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
EP3756684A1 (en) * 2009-05-22 2020-12-30 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
AU2010325748B2 (en) 2009-12-03 2014-04-17 Novartis Ag Hydrophilic filtration during manufacture of vaccine adjuvants
BR112012013427B8 (pt) 2009-12-03 2021-05-25 Novartis Ag circulação dos componentes durante a homogeneização de emulsões
NZ600254A (en) 2009-12-03 2013-10-25 Novartis Ag Arranging interaction and back pressure chambers for microfluidization
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056884B4 (de) 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056871A1 (de) 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
PL3489211T3 (pl) 2010-05-12 2020-12-14 Novartis Ag Ulepszone sposoby otrzymywania skwalenu
US9782474B2 (en) 2010-11-24 2017-10-10 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
EP2782597B1 (en) 2011-11-23 2022-04-13 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
NZ701881A (en) 2012-05-16 2016-10-28 Immune Design Corp Vaccines for hsv-2
CN110938604B (zh) * 2014-03-03 2024-04-05 阿尔伯特爱因斯坦医学院 重组单纯疱疹病毒2(hsv-2)疫苗载体
EP3511020B1 (en) 2014-12-02 2021-01-20 Novartis AG Manufacture of surfactant-containing compositions
JP2019537555A (ja) 2016-09-28 2019-12-26 ジェノセア バイオサイエンシーズ， インコーポレイテッド ヘルペスを処置するための方法および組成物
EP4171514A1 (en) 2020-06-30 2023-05-03 Seqirus UK Limited Cold filtration of oil-in-water emulsion adjuvants

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
DE2949031A1 (de) * 1978-12-15 1980-07-17 Sandoz Ag Vakzine
DE3176404D1 (en) * 1980-04-22 1987-10-08 Pasteur Institut Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
FR2480780B1 (fr) * 1980-04-22 1985-12-06 Pasteur Institut Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
US4317811A (en) * 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
NZ199866A (en) * 1981-03-09 1984-11-09 Cetus Corp Vaccine for prevention of gastroenteric disease:non-pathogenic strain genetically engineered to comprise genes for adhesin and/or toxoids
GB2103622B (en) 1981-06-16 1986-01-15 Genentech Inc Production of foot and mouth disease vaccine from microbially expressed antigens
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
US4593002A (en) * 1982-01-11 1986-06-03 Salk Institute Biotechnology/Industrial Associates, Inc. Viruses with recombinant surface proteins
US4762708A (en) * 1982-02-18 1988-08-09 University Patents, Inc. Materials and methods for herpes simplex virus vaccination
AU1678783A (en) * 1982-07-20 1984-01-26 Molecular Genetics, Inc. Production of herpes simplex viral proteins
US4818694A (en) * 1982-07-20 1989-04-04 American Cyanamid Company Production of herpes simplex viral protein
US4891315A (en) * 1982-10-25 1990-01-02 American Cyanamid Company Production of herpes simplex viral porteins
PT77014B (en) * 1982-07-20 1986-01-24 Molecular Genetics Inc Production of herpes simplex viral proteins
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
EP0133063B1 (en) * 1983-06-23 1987-01-07 Stanley Dr. Person Immunologically reactive non-glycosylated amino acid chains of glycoprotein b of herpes virus types 1 and 2
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
US4618578A (en) * 1984-07-17 1986-10-21 Chiron Corporation Expression of glycoprotein D of herpes simplex virus
ATE230798T1 (de) * 1984-04-06 2003-01-15 Chiron Corp Rekombinanter herpes simplex gb-gd-impfstoff
US4859587A (en) * 1984-06-04 1989-08-22 Institut Merieux Recombinant herpes simplex viruses, vaccines and methods
JPS615786A (ja) * 1984-06-19 1986-01-11 Chemo Sero Therapeut Res Inst 単純ヘルペスウイルス遺伝子を組込んだ組換えｄｎａ、形質転換動物細胞および単純ヘルペスウイルス蛋白質の製法
EP0170169B1 (en) * 1984-07-20 1991-03-20 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Recombinant dna containing a herpes simplex virus gene or a fragment thereof, yeast transformed with said recombinant dna, and method for the production of herpes simplex virus proteins

Also Published As

Publication number Publication date
DE3479085D1 (en) 1989-08-31
IL72785A (en) 1990-07-26
IE842210L (en) 1985-02-28
US5851533A (en) 1998-12-22
IE58030B1 (en) 1993-06-16
ES535554A0 (es) 1986-03-16
JPS60155128A (ja) 1985-08-15
DK412284A (da) 1985-04-11
EP0139417B2 (en) 1999-03-17
JPH08253428A (ja) 1996-10-01
ES8705036A1 (es) 1987-05-01
HK98792A (en) 1992-12-18
EP0139417B1 (en) 1989-07-26
EP0139417A1 (en) 1985-05-02
DK9197A (da) 1997-01-24
ES8605039A1 (es) 1986-03-16
GR80220B (en) 1984-11-15
JP2599350B2 (ja) 1997-04-09
NZ209308A (en) 1991-08-27
AU3242384A (en) 1985-03-07
AU579323B2 (en) 1988-11-24
IL72785A0 (en) 1984-11-30
ES552539A0 (es) 1987-05-01
DK172694B1 (da) 1999-05-31
CA1341181C (en) 2001-02-20

Similar Documents

Publication Publication Date Title
DK412284D0 (da) Vacciner baseret paa membran-bundne proteiner og fremgangsmaade til fremstilling deraf
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK165321C (da) Oxiranderivater og fremgangsmaade til fremstilling deraf
DK298084A (da) Termistorer og fremgangsmaade til fremstilling deraf
NO801133L (no) Interferonproteiner og fremgangsmaate for fremstilling derav
DK256485A (da) Veterinaert praeparat og fremgangsmaade til fremstilling deraf
DK276683D0 (da) Carbapenemer og fremgangsmade til fremstilling deraf
DK362483A (da) Varmeisoleret ledningsroer og fremgangsmaade til fremstilling af samme
DK527584A (da) Fremgangsmaade til fremstilling af substituerede og usubstituerede 2-carbamoylnicotin- eller -3-quinolincarboxylsyrer
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK621484A (da) Acylaminomitosaner og fremgangsmaade til fremstilling deraf
DK184784A (da) Konjugerede filamenter og fremgangsmaade til fremstilling heraf
DK343684D0 (da) Phenyletherderivater og fremgangsmaade til fremstilling deraf
DK343183A (da) Ketoquinoliner og fremgangsmaade til fremstilling deraf
DK445784D0 (da) Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf
DK38284D0 (da) N-(substitueret methyl)-azetidin-2-oner og fremgangsmade til fremstilling heraf
DK26384A (da) Toxoplasmosefaktor og fremgangsmaade til fremstilling deraf
DK81192A (da) Substituerede ethandiimidamider og fremgangsmaade til fremstilling deraf
DK382284D0 (da) Fremgangsmaade til fremstilling af 7-acylamino-3-hydroxy-cephem-4-carbxylsyrer og 7-acylamino-3-hydroxy-1-dethia-1-oxacephem-4-carboxylsrer
DK454784D0 (da) 6-oxodecahydroquinoliner og fremgangsmaade til fremstilling heraf
DK454684A (da) 7beta-acylamino-3-azido-cephalosporiner og fremgangsmaade til fremstilling heraf
DK552284A (da) 2-chlor-3-trifluormethylbenzaldehyd og fremgangsmaade til fremstilling deraf
DK257181A (da) Termoplastiske formmasser og fremgangsmaade til fremstilling deraf
DK284184A (da) 1-phenoxy-3-hydroxyindolylalkylamino-3-propanoler og fremgangsmaade til fremstilling deraf
NO845134L (no) Dialkanoyloksybenzyliden-dialkanoat og fremgangsmaate til fremstilling derav.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired